Skip to content
Clinical Trials – home

Retinol Palmitate: A Comprehensive Guide for Patients

3 / 5
trials open to patients / all trials
5+
Countries

In short

This article examines the use of Retinol Palmitate, a form of vitamin A, in clinical trials for various health conditions. Researchers are investigating its potential benefits in eye disorders, immune system modulation, and neurological diseases. The trials aim to assess the efficacy and safety of Retinol Palmitate supplementation in different patient populations.

What is Retinol Palmitate?

Retinol palmitate is a form of vitamin A that is commonly used in medical treatments and skincare products. It is also known by other names such as vitamin A palmitate, retinyl palmitate, and Aquasol A. This compound is created by combining retinol (pure vitamin A) with palmitic acid, which helps stabilize the vitamin and allows it to be stored in the body.

Medical Uses

Retinol palmitate is being studied and used for various medical conditions, including:

  • Eye disorders: It is being investigated for treating reticular pseudodrusen (RPD) and age-related macular degeneration (AMD), which are eye conditions that can cause vision problems.
  • Premature infants: It is used to supplement very low birth weight babies who may have low vitamin A levels, potentially improving eye and lung development.
  • Vitamin A deficiency: It can be used to treat and prevent vitamin A deficiency, which can affect various body functions, including vision and immune system health.
  • Skin conditions: In skincare, it is used to improve the appearance of wrinkles and pigmentation associated with aging.

How It's Administered

Retinol palmitate can be given in several ways, depending on the condition being treated:

  • Oral supplements: It can be taken by mouth in capsule form. Doses vary widely, from 16,000 IU to 400,000 IU, depending on the condition and patient age.
  • Intramuscular injections: For premature infants, it may be given as an injection into the muscle, typically at a dose of 10,000 IU three times weekly.
  • Topical application: In skincare, it is applied directly to the skin, often in a cream or lotion form.

Potential Benefits

Research suggests that retinol palmitate may offer several benefits:

  • Improved eye health: It may help improve dark adaptation (the ability of the eye to adjust to low light conditions) in people with certain eye disorders.
  • Better outcomes for premature infants: Supplementation may improve retinal function and overall health in very low birth weight babies.
  • Enhanced immune function: In HIV-positive mothers, it may help reduce mother-to-child transmission of HIV during breastfeeding.
  • Skin improvements: When applied topically, it may help reduce the appearance of wrinkles and improve skin pigmentation.

Side Effects and Precautions

While retinol palmitate is generally considered safe when used as directed, it can cause some side effects:

  • Skin irritation: When applied topically, it may cause redness, dryness, or peeling of the skin.
  • Vitamin A toxicity: High doses, especially when taken orally, can lead to vitamin A toxicity. Symptoms may include nausea, headaches, blurred vision, and in severe cases, liver damage.
  • Pregnancy concerns: High doses of vitamin A during pregnancy may cause birth defects. Pregnant women should consult their doctor before taking vitamin A supplements.

Ongoing Research

Several clinical trials are currently investigating the effects of retinol palmitate:

  • Its potential to improve eye function in people with reticular pseudodrusen and age-related macular degeneration.
  • Its effects on very low birth weight premature infants.
  • Its impact on HIV transmission and infant mortality in developing countries.
  • Its effectiveness compared to other compounds (like bakuchiol) in improving skin appearance.

These studies aim to better understand how retinol palmitate works and to determine the most effective and safe ways to use it in various medical conditions.

Questions people often ask

Conditions where Retinol Palmitate is being studied

Each condition opens its own overview and trial list

Trials with Retinol Palmitate

Recruiting trials first

See all 5 →
Quick filters
  • Participants:Children
  • Participants:Adults · Healthy volunteers
  • Participants:Adults · Healthy volunteers
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).